Topamax (topiramate), an anticonvulsant use to treat seizures and severe migraines has been linked to kidney problems, liver disease, birth defects in children who were born from mothers who have taken the drug, and suicidal tendencies.
Topamax was approved by the United States Food and Drug Administration in 2012 and was originally produced by Noramco, Inc., and Ortho-McNeil Neurologics, both are divisions of the healthcare giant, Johnson and Johnson. Ortho-McNeil, now called the Janssen Pharmaceuticals, holds control of more than 21% percent of the epilepsy medication market in the U.S and Topamax is among its bestsellers.
It was in March 2011, when the Food and Drug Administration published a warning specifically to pregnant women who were taking Topamax, that their babies were 21 times more likely to develop cleft defects.
A person who has taken Topamax is also likely to experience its common adverse effects like, such as:
- loss of appetite
- body pains
In 2013, the first Topamax birth defect trial resulted in a winning verdict for the Plaintiff, and the family was awarded $4 million.
The manufacturer allegedly knew about the drug’s birth defect risks, yet hid it from doctors and the public. If you or a friend or a family member suffered from Topamax injuries, consider reaching out for a lawyer’s help about your possible legal options.